Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

F David Burgstahler

Affiliations

  • Director at Wideopenwest Inc. (WOW), 2019-05-13
  • President & Ceo at Organogenesis Holdings Inc. (ORGO), 2018-12-13
  • Large Shareholder, Director at Osmotica Pharmaceuticals Plc (OSMT), 2018-10-19
  • Director at Lantheus Holdings Inc. (LNTH), 2017-09-12
  • Large Shareholder, Director at Inc Research Holdings Inc. (INCR), 2017-05-24
  • Large Shareholder, Director at Angiodynamics Inc (ANGO), 2017-04-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
INCR $43.19 1,000 Large Shareholder, Director 36,065 2016-09-19 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LNTH $16.56 14,415 Director 38,269 2017-09-07 Filing
LNTH $16.56 88,543 Director 247,253 2017-09-07 Filing
LNTH $16.59 3,299 Director 52,684 2017-09-06 Filing
LNTH $16.59 17,524 Director 335,796 2017-09-06 Filing
LNTH $17.08 8,442 Director 55,983 2017-09-05 Filing